| 23 Pharmacodynamics and Antibacterial Resistance PD Lister, ND Hanson, AF Ehrhardt in Theory and Clinical Practice, 463, 2007 | | 2007 |
| AmpC and OprD are not involved in the mechanism of imipenem hypersusceptibility among Pseudomonas aeruginosa isolates overexpressing the mexCD-oprJ efflux pump DJ Wolter, ND Hanson, PD Lister Antimicrobial agents and chemotherapy 49 (11), 4763-4766, 2005 | 43 | 2005 |
| Antibacterial resistance PD Lister Antimicrobial Pharmacodynamics in Theory and Clinical Practice, 339-378, 2001 | 5 | 2001 |
| Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms PD Lister, DJ Wolter, ND Hanson Clinical microbiology reviews 22 (4), 582-610, 2009 | 2436 | 2009 |
| blaKPC RNA Expression Correlates with Two Transcriptional Start Sites but Not Always with Gene Copy Number in Four Genera of Gram-Negative Pathogens AL Roth, PM Kurpiel, PD Lister, ND Hanson Antimicrobial agents and chemotherapy 55 (8), 3936-3938, 2011 | 40 | 2011 |
| Carbapenems in the USA: focus on doripenem PD Lister Expert Review of Anti-infective Therapy 5 (5), 793-809, 2007 | 64 | 2007 |
| Cefepime-Aztreonam: a Unique Double β-Lactam Combination for Pseudomonas aeruginosa PD Lister, WE Sanders Jr, CC Sanders Antimicrobial agents and chemotherapy 42 (7), 1610-1619, 1998 | 53 | 1998 |
| Chromosomally-Encoded Resistance Mechanisms of Pseudomonas aeruginosa Therapeutic Implications PD Lister American Journal of Pharmacogenomics 2, 235-243, 2002 | 38 | 2002 |
| Cirrhosis impairs serum bacteriostasis for Escherichia coli PD Lister, MA Mellencamp, LC Preheim The Journal of laboratory and clinical medicine 120 (4), 633-638, 1992 | 1 | 1992 |
| Clavulanate Induces Expression of the Pseudomonas aeruginosa AmpC Cephalosporinase at Physiologically Relevant Concentrations and Antagonizes the … PD Lister, VM Gardner, CC Sanders Antimicrobial agents and chemotherapy 43 (4), 882-889, 1999 | 140 | 1999 |
| Comparative pharmacodynamics of the 750mg and 500mg doses of levofloxacin against ciprofloxacin-resistant Streptococcus pneumoniae PD Lister, J Black CLINICAL INFECTIOUS DISEASES 33 (7), 1186-1186, 2001 | | 2001 |
| Comparison of ampicillin-sulbactam regimens simulating 1.5-and 3.0-gram doses to humans in treatment of Escherichia coli bacteremia in mice PD Lister, CC Sanders Antimicrobial agents and chemotherapy 39 (4), 930-936, 1995 | 8 | 1995 |
| Effect of drug treatment options on the mobility and expression of blaKPC AL Roth, PD Lister, ND Hanson Journal of Antimicrobial Chemotherapy 68 (12), 2779-2785, 2013 | 10 | 2013 |
| Effects of cirrhosis on the antibacterial activity of serum for Escherichia coli PD Lister Creighton University, 1989 | | 1989 |
| Effects of ethanol on host defenses against pneumococcal pneumonia PD Lister Creighton University, 1992 | | 1992 |
| Efficacy of ampicillin-sulbactam is not dependent upon maintenance of a critical ratio between components: sulbactam pharmacokinetics in pharmacodynamic interactions M Alexov, PD Lister, CC Sanders Antimicrobial agents and chemotherapy 40 (11), 2468-2477, 1996 | 29 | 1996 |
| Emerging resistance problems among respiratory tract pathogens PD Lister Am J Manag Care 6 (Suppl 8), S409-18, 2000 | 39 | 2000 |
| Ethanol impairs neutrophil chemotaxis in vitro but not adherence or recruitment to lungs of rats with experimental pneumococcal pneumonia PD Lister, MJ Gentry, LC Preheim Journal of Infectious Diseases 167 (5), 1131-1137, 1993 | 38 | 1993 |
| EXPERIMENTAL THERAPEUTICS-Clavulanate Induces Expression of the Pseudomonas aeruginosa AmpC Cephalosporinase at Physiologically Relevant Concentrations and Antagonizes the … PD Lister, VM Gardner, CC Sanders Antimicrobial Agents and Chemotherapy 43 (4), 882-889, 1999 | | 1999 |
| EXPERIMENTAL THERAPEUTICS-Pharmacodynamics of Gatifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model: Impact of Area under the Curve/MIC Ratios on … PD Lister Antimicrobial Agents and Chemotherapy 46 (1), 69-74, 2002 | | 2002 |
